Abstract
Thirty-three patients with lung cancer receiving 80 mg m(-2) cisplatin were treated with high-dose dexamethasone (32 mg m(-2) on days 1-3, 16 mg m(-2) on day 4 and 8 mg m(-2) on day 5) combined with granisetron on day 1 and metoclopramide on days 2-5. Twenty-eight (85%) patients had no nausea or vomiting on day 1, and 16 (48%) achieved total control on days 1-5 with acceptable toxicity. High-dose dexamethasone for cisplatin-induced delayed emesis should be further evaluated in a phase III trial.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aapro M. S., Alberts D. S. High-dose dexamethasone for prevention of cis-platin-induced vomiting. Cancer Chemother Pharmacol. 1981;7(1):11–14. doi: 10.1007/BF00258206. [DOI] [PubMed] [Google Scholar]
- Aapro M. S., Alberts D. S., Serokman R. Lack of dexamethasone effect on the antitumor activity of cisplatin. Cancer Treat Rep. 1983 Nov;67(11):1013–1017. [PubMed] [Google Scholar]
- Coates A., Abraham S., Kaye S. B., Sowerbutts T., Frewin C., Fox R. M., Tattersall M. H. On the receiving end--patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol. 1983 Feb;19(2):203–208. doi: 10.1016/0277-5379(83)90418-2. [DOI] [PubMed] [Google Scholar]
- D'Olimpio J. T., Camacho F., Chandra P., Lesser M., Maldonado M., Wollner D., Wiernik P. H. Antiemetic efficacy of high-dose dexamethasone versus placebo in patients receiving cisplatin-based chemotherapy: a randomized double-blind controlled clinical trial. J Clin Oncol. 1985 Aug;3(8):1133–1135. doi: 10.1200/JCO.1985.3.8.1133. [DOI] [PubMed] [Google Scholar]
- Del Favero A., Roila F., Tonato M. Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities. Drug Saf. 1993 Dec;9(6):410–428. doi: 10.2165/00002018-199309060-00004. [DOI] [PubMed] [Google Scholar]
- Gebbia V., Testa A., Valenza R., Cannata G., Tirrito M. L., Gebbia N. Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy. A prospective randomized trial. Cancer. 1995 Nov 15;76(10):1821–1828. doi: 10.1002/1097-0142(19951115)76:10<1821::aid-cncr2820761022>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
- Kris M. G., Gralla R. J., Tyson L. B., Clark R. A., Cirrincione C., Groshen S. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol. 1989 Jan;7(1):108–114. doi: 10.1200/JCO.1989.7.1.108. [DOI] [PubMed] [Google Scholar]
- Kris M. G., Pisters K. M., Hinkley L. Delayed emesis following anticancer chemotherapy. Support Care Cancer. 1994 Sep;2(5):297–300. doi: 10.1007/BF00365581. [DOI] [PubMed] [Google Scholar]
- Moreno I., Rosell R., Abad A., Barnadas A., Carles J., Ribelles N., Solano V., Font A. Comparison of three protracted antiemetic regimens for the control of delayed emesis in cisplatin-treated patients. Eur J Cancer. 1992;28A(8-9):1344–1347. doi: 10.1016/0959-8049(92)90515-4. [DOI] [PubMed] [Google Scholar]
- Shinkai T., Saijo N., Eguchi K., Sasaki Y., Tamura T., Fujiwara Y., Mae M., Fukuda M., Ohe Y., Sasaki S. Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial. Jpn J Clin Oncol. 1989 Mar;19(1):40–44. [PubMed] [Google Scholar]
- Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials. 1989 Mar;10(1):1–10. doi: 10.1016/0197-2456(89)90015-9. [DOI] [PubMed] [Google Scholar]
- Smyth J. F. New directions for anti-emetic research. Ann Oncol. 1994 Sep;5(7):569–570. doi: 10.1093/oxfordjournals.annonc.a058924. [DOI] [PubMed] [Google Scholar]